Herpes Marker Testing Market: By Test Type (Nucleic Acid Amplification Test, Viral Culture Tests, Antibody-Antigen Based Tests), By Virus Type (HSV-1, HSV-2, HSV-1 & HSV-2), By Application (Clinical Diagnosis, Research Use), By End User (Hospitals, Research Laboratories, Diagnostic Centres, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Herpes Marker Testing Market is expected to grow at a CAGR of 6.4% from 2023-2029. Driving factors for the global herpes marker testing market include a rise in prevalence of the herpes infections across the globe. In addition, a rise in government support for the development of accurate diagnostics for diseases like herpes and growing awareness related to the available diagnostic tests for herpes are expected to boost the market growth over the forecast period. Numerous regional and international firms compete in the global market for herpes marker testing products, which is constantly evolving due to technology improvements and new product introductions. The prevalence of herpes in the population, increased government backing, growing awareness, rising healthcare expenditures, new product introductions, and a growing focus on evidence-based medicine are all driving the herpes marker testing industry. Some obstacles are limiting market revenue growth, such as limited access to diagnostic services in rural places, insufficient R&D initiatives, pricing pressures, and severe restrictions. To stay competitive in the global market, companies are working on acquisitions, mergers, and new product approvals and launches. The market for herpes marker testing is separated into three types of tests: viral culture tests, nucleic acid amplification-based kits, and antibody/antigen-based kits. Because of the large product availability and high physician preference for this test type, the antibody/antigen-based kits segment dominates the market with over 50% market share estimated during the projection period. However, due to the increased use of PCR technique in diagnosis due to its high sensitivity, specificity, and low time consumption, the nucleic acid amplification-based kits segment is expected to develop at the fastest rate over the projection period.

Herpes Marker Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.4%

Largest Market

North America

Fastest Growing Market

North America
Herpes Marker Testing Market Dynamics

Advancements in biotechnology and new product launch in herpes marker testing projected to bolster the market share. However, poor access of diagnostics in the under developing countries, cost involved in biomarker development and prices of diagnosis are expected to hamper the global herpes marker testing market over the forecast period.

Herpes Marker Testing Market Segmentation

By Test Type
  • Nucleic acid amplification test
  • Viral Culture Tests
  • Antibody-Antigen Based tests
By Virus Type
  • HSV-1
  • HSV-2
  • HSV-1 & HSV-2
By Application
  • Clinical Diagnosis
  • Research Use
By End User
  • Hospitals
  • Research Laboratories
  • Diagnostic Centres
  • Others

Frequently Asked Questions

The herpes marker testing market size was valued at USD x billion in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), BioMérieux SA (France), DiaSorin (Italy), Hoffmann-La Roche Ltd. (Switzerland), Luminex Corporation (U.S.)

Key Features of the Reports

  • The herpes marker testing market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Herpes Marker Testing Market Introduction 
2.1.Global Herpes Marker Testing Market  - Taxonomy
2.2.Global Herpes Marker Testing Market  - Definitions
2.2.1.Test Type
2.2.2.Virus Type
2.2.3.Application
2.2.4.By End User
2.2.5.Region
3.Global Herpes Marker Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Herpes Marker Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Herpes Marker Testing Market  By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Nucleic acid amplification test
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Viral Culture Tests
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Antibody-Antigen Based tests
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Herpes Marker Testing Market  By Virus Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. HSV-1
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. HSV-2
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. HSV-1 & HSV-2
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Herpes Marker Testing Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Clinical Diagnosis
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Research Use
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Herpes Marker Testing Market  By By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Research Laboratories
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Diagnostic Centres
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Herpes Marker Testing Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Nucleic acid amplification test
10.1.2.Viral Culture Tests
10.1.3.Antibody-Antigen Based tests
10.2.  Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.HSV-1
10.2.2.HSV-2
10.2.3.HSV-1 & HSV-2
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Clinical Diagnosis
10.3.2.Research Use
10.4.  By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Research Laboratories
10.4.3.Diagnostic Centres
10.4.4.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Nucleic acid amplification test
11.1.2.Viral Culture Tests
11.1.3.Antibody-Antigen Based tests
11.2.  Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.HSV-1
11.2.2.HSV-2
11.2.3.HSV-1 & HSV-2
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Clinical Diagnosis
11.3.2.Research Use
11.4.  By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Research Laboratories
11.4.3.Diagnostic Centres
11.4.4.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Nucleic acid amplification test
12.1.2.Viral Culture Tests
12.1.3.Antibody-Antigen Based tests
12.2.  Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.HSV-1
12.2.2.HSV-2
12.2.3.HSV-1 & HSV-2
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Clinical Diagnosis
12.3.2.Research Use
12.4.  By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Research Laboratories
12.4.3.Diagnostic Centres
12.4.4.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Nucleic acid amplification test
13.1.2.Viral Culture Tests
13.1.3.Antibody-Antigen Based tests
13.2.  Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.HSV-1
13.2.2.HSV-2
13.2.3.HSV-1 & HSV-2
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Clinical Diagnosis
13.3.2.Research Use
13.4.  By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Research Laboratories
13.4.3.Diagnostic Centres
13.4.4.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Nucleic acid amplification test
14.1.2.Viral Culture Tests
14.1.3.Antibody-Antigen Based tests
14.2.  Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.HSV-1
14.2.2.HSV-2
14.2.3.HSV-1 & HSV-2
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Clinical Diagnosis
14.3.2.Research Use
14.4.  By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Research Laboratories
14.4.3.Diagnostic Centres
14.4.4.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Laboratories (U.S.)
15.2.2.Thermo Fisher Scientific, Inc. (U.S.)
15.2.3.BioMérieux SA (France)
15.2.4.DiaSorin (Italy)
15.2.5.Hoffmann-La Roche Ltd. (Switzerland)
15.2.6.Luminex Corporation (U.S.)
15.2.7.Quidel Corporation (U.S.)
15.2.8.Qiagen N.V. (Germany)
15.2.9.Merck KGaA (Germany)
15.2.10.Hologic Inc. (U.S.)
15.2.11.Norgen Biotek Corp. (Canada)
15.2.12.Teco Diagnostics (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Abbott Laboratories (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • BioMérieux SA (France)
  • DiaSorin (Italy)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Luminex Corporation (U.S.)
  • Quidel Corporation (U.S.)
  • Qiagen N.V. (Germany)
  • Merck KGaA (Germany)
  • Hologic Inc. (U.S.)
  • Norgen Biotek Corp. (Canada)
  • Teco Diagnostics (U.S.)
  • Meridian Bioscience Inc. (U.S.)

Adjacent Markets